JGRJX
Price
$39.11
Change
-$0.10 (-0.26%)
Updated
Jul 8 closing price
Net Assets
22.15B
RGACX
Price
$79.35
Change
-$0.06 (-0.08%)
Updated
Jul 8 closing price
Net Assets
320.87B
Interact to see
Advertisement

JGRJX vs RGACX

Header iconJGRJX vs RGACX Comparison
Open Charts JGRJX vs RGACXBanner chart's image
JPMorgan Growth Advantage R2
Price$39.11
Change-$0.10 (-0.26%)
VolumeN/A
Net Assets22.15B
American Funds Growth Fund of Amer R3
Price$79.35
Change-$0.06 (-0.08%)
VolumeN/A
Net Assets320.87B
JGRJX vs RGACX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
JGRJX vs. RGACX commentary
Jul 09, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is JGRJX is a Buy and RGACX is a StrongBuy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
RGACX has more cash in the bank: 321B vs. JGRJX (22.1B). RGACX pays higher dividends than JGRJX: RGACX (0.07) vs JGRJX (0.00). JGRJX was incepted earlier than RGACX: JGRJX (8 years) vs RGACX (23 years). JGRJX (1.37) is less costly to investors than RGACX (0.94). JGRJX is a more actively managed with annual turnover of: 28.00 vs. RGACX (25.00). JGRJX has a lower initial minimum investment than RGACX: JGRJX (0) vs RGACX (250). RGACX annual gain was more profitable for investors over the last year : 8.78 vs. JGRJX (4.32). JGRJX return over 5 years is better than : 48.57 vs. RGACX (42.55).
JGRJXRGACXJGRJX / RGACX
Total Expense Ratio1.250.94133%
Annual Report Gross Expense Ratio1.370.94146%
Fund Existence8 years23 years-
Gain YTD6.21910.30760%
Front LoadN/AN/A-
Min. Initial Investment0250-
Min. Initial Investment IRAN/AN/A-
Net Assets22.1B321B7%
Annual Yield % from dividends0.000.07-
Returns for 1 year4.328.7849%
Returns for 3 years67.7852.65129%
Returns for 5 years48.5742.55114%
Returns for 10 yearsN/A81.14-
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
IKT1.930.04
+2.12%
Inhibikase Therapeutics
STGW4.53-0.03
-0.66%
Stagwell
EPR58.85-0.65
-1.09%
EPR Properties
TOMZ1.05-0.03
-2.78%
TOMI Environmental Solutions
EC8.87-0.30
-3.27%
Ecopetrol SA